Urticaria pathophysiology
Pro Research Analysisby 
Searched over 200M research papers for "urticaria pathophysiology"
Mast Cell Activation and Histamine Release in Urticaria Pathophysiology
The central mechanism in urticaria pathophysiology is the activation of mast cells in the skin, which leads to the release of histamine and other inflammatory mediators. This process increases the permeability of subcutaneous capillaries, resulting in the characteristic wheals and localized skin edema seen in urticaria 138. Basophils also play a role, especially in the onset phase of chronic spontaneous urticaria (CSU), by triggering endovascular changes that contribute to the development of skin eruptions .
Autoimmune and Immune System Involvement in Urticaria
A significant proportion of chronic urticaria cases are linked to autoimmune mechanisms. Up to half of CSU patients have autoimmunity involving mast cell receptors, with both IgE- and IgG-mediated pathways implicated. Type I autoimmunity (autoallergy) involves IgE antibodies against self-antigens, while type IIb autoimmunity involves IgG antibodies targeting the IgE receptor or IgE itself on mast cells and basophils. These immune responses lead to the activation and degranulation of these cells, perpetuating inflammation and symptoms 1378.
Genetic and Molecular Pathways in Urticaria
Genetic studies have identified several sequence variants associated with urticaria, particularly in genes related to type 2 immune responses and mast cell biology. These include genes such as CBLB, FCER1A, GCSAML, STAT6, and others involved in innate immunity and NF-κB signaling. These findings highlight the importance of both IgE-dependent and IgE-independent pathways in urticaria pathogenesis .
Bruton's tyrosine kinase (BTK) is a key molecule in the signaling pathways of both the IgE receptor and B-cell receptor, making it a promising therapeutic target. BTK inhibitors have shown effectiveness in reducing disease activity in CSU, especially in patients who do not respond to antihistamines 389.
Coagulation and Fibrinolysis in Urticaria Pathophysiology
Recent research has shown that the coagulation and fibrinolysis systems are involved in urticaria, particularly in chronic forms. Biomarkers such as D-dimer and prothrombin fragment 1+2 (F1+2) are elevated during disease exacerbations and decrease with remission. These markers correlate with disease severity and may predict treatment response. Coagulation factors like tissue factor and thrombin can increase vascular permeability directly and indirectly by promoting mast cell degranulation 45.
Neuro-Immune-Cutaneous Interactions and Psychological Stress
The skin acts as both a perceiver and target of psychological stress, which can influence urticaria through neuro-immune-cutaneous pathways. Stress-related neuropeptides, hormones, and inflammatory mediators interact with immune cells in the skin, potentially triggering or worsening urticaria. This complex crosstalk may explain why psychological stress is often associated with CSU onset and flares .
Inflammatory Networks and Cytokine Involvement
Multiple cytokines and chemokines are involved in the inflammatory networks of urticaria, contributing to the recruitment and activation of immune cells such as eosinophils, basophils, and mast cells. These mediators help sustain the inflammatory response and prime the skin for recurrent symptoms .
Conclusion
Urticaria pathophysiology is complex and involves mast cell and basophil activation, autoimmune mechanisms, genetic predispositions, coagulation pathways, and neuro-immune interactions. Understanding these interconnected processes is crucial for developing more effective and targeted treatments for both acute and chronic urticaria 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic